{"gao_id": "GAO-19-446", "published": "2019-05-20T12:00:00Z", "released": "2019-05-20T08:00:00Z", "summary": "Medicare's drug management programs identify beneficiaries at risk of abusing opioids and take steps to reduce their risk. These programs look at factors that can contribute to opioid abuse and misuse, such as being prescribed a high daily dosage or receiving opioids from multiple prescribers. Health care providers then review each case. If they decide a patient is at risk, this may trigger more limits...", "title": "Prescription Opioids: Voluntary Medicare Drug Management Programs to Control Misuse", "topics": ["Medicare plans", "Controlled substances", "Health care", "Pharmacy", "Patient care", "Risk management", "Prescription drugs", "Addiction", "Drugs", "Deaths", "Health Care", "Beneficiaries", "Medicare", "Case management"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-19-446", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-19-446-highlights.pdf"}, {"title": "Full Report (21 pages)", "url": "https://www.gao.gov/assets/gao-19-446.pdf"}, {"title": "Accessible PDF (22 pages)", "url": "https://www.gao.gov/assets/700/699585.pdf"}]}